An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells

Tumor Necrosis Factor Induces Bcl-2 and Bcl-x Expression through NFκB Activation in Primary Hippocampal Neurons

Michio Tamatani, Yong Ho, Hideo Matsuzaki et al. · Journal of Biological Chemistry · 1999 · 549 citations · Full text

Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease

Nadine Tatton · Experimental Neurology · 2000 · 405 citations

Apoptosis, Cell Death, Caspase 3 +9

Transfection‐enforced Bcl‐2 overexpression and an anti‐Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde‐3‐phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, <i>N</i>‐methyl(<i>R</i>)salsolinol

Wakako Maruyama, Yukihiro Akao, Moussa B. H. Youdim et al. · Journal of Neurochemistry · 2001 · 168 citations

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse

Wei Huang, Yun Chen, Esther Shohami et al. · European Journal of Pharmacology · 1999 · 141 citations

Medicine, Neuropharmacology, Head Injury +10

Neuroprotective Action of Cycloheximide Involves Induction of Bcl-2 and Antioxidant Pathways

Katsutoshi Furukawa, Steven Estus, Weiming Fu et al. · The Journal of Cell Biology · 1997 · 121 citations · Full text